Hartwig Klinker

Extended Treatment Duration for Hepatitis C Virus Type 1: Comparing 48 Versus 72 Weeks of Peginterferon-Alfa-2a Plus Ribavirin

Thomas Berg, Michael Wagner, Samer Nasser et al. · Gastroenterology · 2006 · 519 citations · Full text

Peginterferon-alfa-2a Plus Ribavirin, Hepatology, Hepatitis C +10

Patterns of Resistance-Associated Substitutions in Patients With Chronic HCV Infection Following Treatment With Direct-Acting Antivirals

Julia Dietz, S. Süsser, Johannes Vermehren et al. · Gastroenterology · 2017 · 147 citations

Viral Hepatitis, Direct-acting Antivirals, Antiviral Therapy +8

Ledipasvir plus sofosbuvir fixed-dose combination for 6 weeks in patients with acute hepatitis C virus genotype 1 monoinfection (HepNet Acute HCV IV): an open-label, single-arm, phase 2 study

Katja Deterding, Christoph D. Spinner, Eckart Schott et al. · The Lancet Infectious Diseases · 2016 · 129 citations

Hepatology, Hepatitis C, Viral Hepatitis +8

RNA Interference Therapy With ARC‐520 Results in Prolonged Hepatitis B Surface Antigen Response in Patients With Chronic Hepatitis B Infection

Man‐Fung Yuen, Ingolf Schiefke, Jung‐Hwan Yoon et al. · Hepatology · 2019 · 127 citations · Full text

The protease inhibitor, GS-9256, and non-nucleoside polymerase inhibitor tegobuvir alone, with ribavirin, or pegylated interferon plus ribavirin in hepatitis C

Stefan Zeuzem, Peter Buggisch, Kosh Agarwal et al. · Hepatology · 2011 · 113 citations · Full text